Transcranial Magnetic Stimulation (TMS)

Left prefrontal repetitive transcranial magnetic stimulation (rTMS) is covered for adults with confirmed severe Major Depressive Disorder who meet defined treatment-resistance or intolerance criteria, have failed an adequate trial of evidence-based psychotherapy, and whose treatment is ordered and supervised by a psychiatrist experienced in TMS. Major exclusions include a history of seizures (with limited exceptions), current psychotic disorders, specific neurological conditions, and implanted magnetic-sensitive devices or metal within 30 cm of the coil; all other uses are considered experimental. Retreatment is allowable for relapse when prior response exceeded a 50% improvement on standardized rating scales and initial criteria were met.

"TMS may be covered when prescribed and administered by a licensed physician knowledgeable in the use of repetitive transcranial magnetic stimulation (rTMS)."